Netherlands vs Norway: Share of E. coli infections resistant to cephalosporins
Netherlands
7.6%
in 2022
Norway
5.1%
in 2021
Netherlands rank
43rd
Norway rank
46th
Share of E. coli infections resistant to cephalosporins over time
- Netherlands
- Norway
How they compare
Netherlands currently reports 7.6% against 5.1% in Norway, a difference of 2.5%.
That makes Netherlands's figure about 1.5 times Norway's.
Across all 5 years both countries report, Netherlands has been ahead every year.
Netherlands ranks 43rd and Norway ranks 46th of 46 countries.
Netherlands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Netherlands | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6.9% | 6.0% | 0.8% | Netherlands |
| 2020s | 6.6% | 5.2% | 1.4% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Netherlands or Norway?
- Netherlands, at 7.6% against 5.1% in Norway as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Netherlands and Norway?
- 2.5%, with Netherlands ahead.
- How many years of comparable data are there for Netherlands and Norway?
- 5 years are reported by both, from 2017 to 2021.
- How do Netherlands and Norway rank globally for share of e. coli infections resistant to cephalosporins?
- Netherlands ranks 43rd and Norway ranks 46th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).